Background Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence and outcomes, including mortality. However, it is unclear whether the associations between cardiovascular disease and common measures of socioeconomic status-wealth and education-differ among high-income, middle-income, and low-income countries, and, if so, why these differences exist. We explored the association between education and household wealth and cardiovascular disease and mortality to assess which marker is the stronger predictor of outcomes, and examined whether any differences in cardiovascular disease by socioeconomic status parallel differences in risk factor levels or differences in management.
Introduction
In high-income countries, low socioeconomic status is associated with an increased risk of cardiovascular disease and mortality. [1] [2] [3] Whether this association also applies to low-income and middle-income countries, which have the highest burden of cardiovascular disease, 4, 5 has been less well studied, and findings on the association between socioeconomic status and cardiovascular health have been inconsistent. 6, 7 Clarifying the nature of the association between socioeconomic status and cardiovascular disease in low-income and middleincome countries, and understanding the under lying reasons or related factors, is necessary for the development of contextually appropriate strategies to mitigate health disparities. However, socioeconomic status is a multidimensional construct 8 related to both adequacy of financial resources and educational attain ment. Therefore, the meaning and effects of socio economic status on cardio vascular disease might vary according to context, indicating the need for research in different settings. Specifically, with rapid urbanisation and societal change in low-income and middle-income countries, as well as increasing rates of cardiovascular disease, there is a need for up-to-date studies that can capture the current situation. Although some data exist on socioeconomic gradients in cardiovascular disease in low-income and middle-income countries, [9] [10] [11] [12] [13] [14] to our knowledge no study has used consistent methods to compare cardiovascular disease or death by socio economic status, nor has any study explored potential reasons for any observed differences. Furthermore, to our knowledge, existing studies have not used consistent methods or studied a large number of countries at different levels of economic development.
The Prospective Urban Rural Epidemiologic (PURE) study is a large-scale prospective cohort study that
Research in context
Evidence before this study We searched PubMed for articles published up to Feb 13, 2018 , with the search terms (MESH and All Fields) "socioeconomic status", "cardiovascular disease", and "epidemiologic, comparison" and no language limits and identified 266 abstracts; after addition of the term "management" another 42 abstracts were returned. Furthermore, we used the Journal/Author Name Estimator search engine on the abstract of this manuscript to identify similar publications and found another 20 abstracts. Two authors (KBB, AR) searched all abstracts for cross-sectional and cohort studies that compared cardiovascular morbidity and mortality between countries of different socioeconomic levels (high-income, middle-income, and low-income countries) and between urban and rural communities. Altogether, we identified 49 relevant abstracts. We found several studies in high-income countries, but only altogether eight in other countries, that addressed disparities in socioeconomic position and cardiovascular complications and made comparisons between urban and rural areas. However, we found no studies that compared countries of high-income, low-income, and middle-income socioeconomic status in these respects. Therefore, although some data on socioeconomic gradients in cardiovascular disease in low-income and middle-income countries exist, we did not identify any that used consistent methods or compared findings across several countries at different levels of economic development.
Added value of this study
In high-income countries, low socioeconomic status is associated with an increased risk of cardiovascular disease.
Whether this association also applies in low-income and middle-income countries, which have the largest burden of cardiovascular disease, has been less well studied and the results of existing studies are inconsistent. We found that low education was a stronger marker for cardiovascular disease and mortality than was wealth. This association was most marked in low-income countries (mainly India, Pakistan, and Bangladesh), less marked in middle-income countries, and least evident in high-income countries (mainly Canada and Sweden). Differences in risk factor proportions, which to a large extent were lower in individuals living in low-income countries, did not explain the different risks of cardiovascular disease in different educational groups. By contrast, less educated individuals in low-income countries received fewer medications for hypertension, diabetes, or secondary prevention and were less likely to quit smoking or have a healthy diet.
Implications of all the available evidence Education, rather than wealth, was the factor most strongly associated with the study primary outcomes, with low education being associated with an increased risk of major cardiovascular disease and higher case fatality, despite lower proportions of cardiovascular risk factors in low-income countries than in high-income countries. Improved education and access to effective health care might mitigate some of the substantial excess burden of cardiovascular disease and mortality in low-income countries and narrow global health inequalities. Data are n (%), mean (SD), or n/N (%). *Self-reported or on medications, or blood pressure ≥140/≥90 mm Hg. †Plasma glucose concentrations were available in 122 711 participants. ‡Diagnosed with stroke, coronary heart disease, heart failure, or other heart disease before baseline visit. recruited individuals from high-income, low-income, and middle-income countries, providing an opportunity to explore associations between socioeconomic status and cardiovascular disease across settings at varying economic levels. In this Article, we describe the association between two markers of socioeconomic status (education and household wealth) and cardiovascular disease and mortality to assess which marker is the stronger predictor of outcomes. We also examined whether any differences in cardiovascular disease by socioeconomic status paralleled differences in risk factor levels or differences in management (using markers of health care such as hypertension control, diabetes care, and use of secondary prevention strategies).
Methods

Study design and participants
The design, methods (including sampling, information gathered, and follow-up strategy), and participant characteristics of the PURE study have been published previously. 15 Briefly, adults aged between 35 years and 70 years from 367 urban and 302 rural communities in 20 countries (Tanzania, Zimbabwe, Bangladesh, Pakistan, India, occupied Palestinian territory, China, Colombia, Iran, South Africa, Malaysia, Argentina, Turkey, Brazil, Poland, Chile, Saudi Arabia, United Arab Emirates, Canada, and Sweden) were included. Details of sampling, information gathered, and follow-up strategy have been previously reported in several publications. 15, 16 For the present study, follow-up event data were available until Sept 20, 2017 . The countries were grouped according to the 2006 World Bank income classifications 17 based on gross national product per capita at the time when data collection began (appendix). Men and women aged between 35 years and 70 years, who were expected to remain in their community for at least 4 years, were eligible for inclusion. The response rate was 72%.
Although modest differences exist between the PURE household population and national data, these differences are unlikely to have much of an effect on the exposuredisease associations derived in PURE, and demographics and mortality were generally similar to national statistics. 18 Ethics committees at each centre approved the protocol and all participants provided written informed consent.
Procedures
We collected data on families and households in two questionnaires, the first recording sociodemographic information on all inhabitants of the household and the second recording information on house structure and amenities. Data on cardiovascular risk factors (tobacco use, history of hypertension, diabetes, psychosocial factors, diet, physical activity, and physical measures) were recorded using standardised questions and methods in a third questionnaire, which was sup plemented by physical examination, including blood pressure, anthropometric measures, spirometry, and an electrocardiogram. Further questionnaires assessed diet (food frequency) and physical activity by use of standardised instruments. Consenting participants also provided a fasting blood sample (appendix). The non-cholesterol INTERHEART risk score, 19 which integrates information on age, sex, smoking, diabetes (self-report or fasting glucose >7·0 mmol/L), high blood pressure (blood pressure >140/>90 mm Hg or self-report), family history of heart disease, waist to hip ratio, psychosocial factors, diet (healthy eating score), and physical activity, was used to describe overall risk factor levels (appendix). 15 , 16 The quality of data collection was maintained by the use of standardised protocols, centralised training, and stringent quality control at the project office.
We assessed socioeconomic status using education and a household wealth index. Education was categorised as no or primary school education only (lowest), secondary school education (intermediate), or higher education, defined as completion of trade school, college, or university (highest). Household wealth, calculated at the household level and with household data, was defined by an index on the basis of ownership of assets and housing characteristics, 20 validated in several countries, and documented to be a robust measure of wealth, consistent with measures of income and expenditure.
Outcomes
Primary outcomes were major cardiovascular disease (a composite of cardiovascular deaths, strokes, myocardial infarction, and heart failure; appendix), cardiovascular mortality, and all-cause mortality.
Information on specific events was obtained from participants or their family, who were contacted at regular intervals after the questionnaires were delivered. Followup of participants was done at 3-year intervals and information on clinical events was obtained from participants or family members for deceased participants. All follow-up visits were done either by visiting households or by telephone calls from participants, or, in countries such as Canada, the participants were invited to the central office to complete the follow-up visit. Events were adjudicated centrally in each country by trained physicians by use of standardised definitions, verbal autopsies, and review of documents.
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Statistical analysis
We used direct standardisation to calculate the agestandardised and sex-standardised incidence rates (per 1000 person-years) for cardiovascular events and deaths. We used multi-level Cox proportional hazard models to obtain the hazard ratios (HRs) for all-cause mortality, fatal cardiovascular disease, and major cardiovascular disease. In the multi-level structure models, we considered individual participants nested in centres and considered centres as a random intercept effect. We mutually adjusted HRs for education and wealth, in addition to age, sex, urban versus rural, baseline cardiovascular disease, and INTERHEART risk score. We included the interaction terms of region and education and region and wealth, where region denoted high-income, middle-income, or low-income countries.
We tested the assumption of proportional hazard with log of the negative log of Kaplan-Meier estimates of the survival function versus the log time for evidence of nonparallelism.
Defining countries according to country income might not adequately capture inequalities across the entire distribution of education or wealth. Consequently, we also used the Wagstaff index, which has been proposed as an alternative to the concentration index when the health variable is bounded (ie, has an upper and lower For UN population data see https://population.un.org/wpp/ DataQuery/ limit). 21, 22 The Wagstaff index is the concentration index divided by 1 minus the mean of the health variable, producing a value between -1 and 1.
We calculated case fatality rates in the 28 days following myocardial infarction, stroke, and heart failure adjusted for age and sex. We calculated age-adjusted and sexadjusted case fatality rates by education or wealth and stratified by country income with the method of least squares to fit general linear models. Reported p trend values on the figures are for case fatality rates within each country income grouping using the χ² test for trend. Given the multiple comparisons, p values should be interpreted with caution, unless very small (eg, p<0·0001). All analyses were done with SAS version 9.4 and all figures were drawn in R version 3.2.5.
Role of the funding source
The funders and sponsors of the study had no role in the study design and conduct, data collection, data analysis, data interpretation, writing of the report, or the decision to submit the manuscript for publication. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Results
Recruitment to the study began on Jan 12, 2001, with most participants enrolled between Jan 6, 2005, and Dec 4, 2014. 160 299 (87·9%) of 182 375 participants with baseline data had available follow-up event data, and were aged between 35 and 70 years and from 20 countries (other countries and participants were enrolled too recently to have had a follow-up visit). After exclusion of 6130 (3·8%) partici pants without complete baseline or follow-up data, 154 169 remained for analysis (appendix). Populations had diverse sizes, with India contributing 81% of the low-income population, and China 45% of the middle-income population, whereas Canada contributed 60% of the high-income population. 4337 (12·7%) of 34 085 participants from low-income countries had a university, college, or trade school education, compared with 15 161 (14·7%) of 102 843 par ticipants in middle-income countries and 10 109 (58·6%) of 17 241 participants in high-income countries (table 1) . Corresponding proportions for primary education or less were 18 095 (53·1%) for low-income countries, 45 820 (44·6%) in middle-income countries, and 2137 (12·4%) in high-income countries. Across all countries, participants with a high level of education were younger, and less likely to be women. In high-income countries, individuals with a low level of education had higher INTERHEART risk scores than did those with higher levels of education, and more frequently had hypertension, diabetes, and previous cardiovascular disease, whereas the opposite was true for low-income countries, with the exception of previous cardiovascular disease, which was similar across all education categories (table 1) . We recorded the proportion of participants with INTERHEART risk scores score greater than 10 ( figure 1) . With respect to the findings for individual countries, India and Bangladesh, which constituted 88% of the lowincome population, both had higher INTERHEART risk scores among people with higher levels of education, although findings for the smaller samples in the other three low-income countries were heterogeneous (data not shown). Characteristics by wealth categories and individual components of the INTERHEART risk score by education are shown in the appendix.
Over a mean follow-up duration of 7·5 years until Sept 20, 2017, we recorded 7744 deaths and 6936 cases of major cardiovascular disease. Mortality varied substantially by education and country income (table 2), with the highest mortality in low-income countries and in those with the lowest levels of education across country income categories. The group with the lowest level of education in low-income countries had an agestandardised and sex-standardised mortality rate of 16·0 (95% CI 15·0-17·0) per 1000 person years-more than five times that of people with the highest level of education in high-income countries (2·6 per 1000 person-years, 95% CI 2·2-3·0). Similar results were also seen for cardiovascular mortality (table 2) . When stratified by household wealth, total and cardiovascular mortality rates varied from 16·4 (95% CI 16·0-17·0) and 4·1 (3·7-4·6) per 1000 person-years, respectively, among the poorest third of participants in low-income countries to 3·0 (2·4-3·6) and 0·6 (0·3-0·9) per 1000 person-years, respectively, among the richest third of participants in high-income countries. Incidence of major cardiovascular disease was similar for people with the lowest levels of education across low-income, middle-income, and highincome countries (7·5 per 1000 person-years, 95% CI 7·0-8·0, in low-income countries, 7·3 per 1000 personyears, 6·9-7·6, in middle-income countries, and 7·3 per 
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None or primary school Secondary Trade school, college, or university Education 1000 person-years, 5·7-8·9, in high-income countries). The incidence rates for those with the highest level of education were 3·5 per 1000 person-years (95% CI 2·7-4·3) in low-income countries, 4·9 per 1000 personyears (4·5-5·4) in middle income countries, and 3·7 per 1000 person-years (3·2-4·2) in high-income countries. The association between wealth and outcomes was weaker than the same comparisons between education and outcomes, and this was consistently observed among men and women (data not shown).
In multivariable models that simultaneously adjusted for education and wealth, in addition to age, sex, urban versus rural setting, baseline cardiovascular disease, and INTERHEART risk score, education was a strong independent predictor for total mortality (HR 2·76, 95% CI 2·29-3·31, in low-income countries, 1·80, 1·58-2·06, in middle-income countries, and 1·50, 1·14-1·98, in high-income countries) when comparing the lowest level of education with the highest level of education (p interaction <0·0001; figure 2). We observed similar results for major cardiovascular disease (2·23, 1·79-2·77, for low-income countries, 1·59, 1·42-1·78, for middle-income countries, and 1·23, 0·96 to 1·58, for high-income countries; p interaction <0·0001). Level of education was a far stronger predictor for major cardiovascular disease and all-cause mortality than was wealth. We also calculated mutually adjusted HRs by education and wealth, stratified by countries grouped by income, but adjusted for separate risk factors rather than the composite INTERHEART risk score (appendix). Sensitivity analyses from which subjects with previous cardiovascular disease were excluded provided similar results (appendix).
Cardiovascular event rates and death rates by individual country ranked by their gross domestic product (GDP) are shown in figure 3 . The only low-income country with a sufficient number of events for analysis in people with a high level of education was India, but we observed similar patterns in the other low-income countries, for which we were able to compare middle and low levels of education.
The Wagstaff index results reaffirmed our conclusions, specifically that although the patterns of inequality were broadly similar for education and the wealth index, the strength of the association between education and outcomes was stronger than the corresponding association between the wealth index and outcomes, as indicated by the relatively lower index estimates for wealth (appendix). Importantly, the index estimates were consistent with our conclusions from figure 2 and table 2.
5509 (79·4%) of 6936 major cardiovascular disease events recorded occurred in participants with no previous cardiovascular disease at baseline, of whom 1407 (25·5%) died within 28 days. We observed substantial differences between countries at different income levels with respect to absolute case fatality rates (CFRs), and in the association between level of education and CFR (p interaction <0·0001 for country income and education; figure 4 ). The gradients in CFRs between the highest and the lowest levels of education were steepest in lowincome and middle-income countries, and we observed no gradient in high-income countries, where there were fewer overall fatalities. Corresponding data for wealth are shown in the appendix.
Hypertension and diabetes are among the most important risk factors for cardiovascular disease and related mortality and treating them is proven to reduce complications, as does secondary prevention in people with known cardiovascular disease. Therefore, we examined variations in the medical treatment of hypertension and diabetes, and in secondary prevention, by education and country income as a marker of management of these conditions (table 3) . 27 327 (46·6%) of 58 642 participants with hypertension were aware of their condition. In the high-income countries included in our study, medical treatment did not vary by education, whereas we found a consistent and significant inverse association between level of education and treatment in low-income and middle-income countries (p interaction <0·0001).
13 207 (8·6%) of 153 934 participants had known diabetes-1609 (9·3%) in high-income countries, 8224 (8·0%) in middle-income countries, and 3194 (9·4%) in low-income countries (table 3) . 1198 (74·5%) of 1609 people with known diabetes in high-income countries used hypoglycaemic drugs, with no differences by education, and 4349 (52·9%) of 8224 people with known diabetes in middle-income countries used hypoglycaemic drugs, with slightly lower use with lower levels of education. Among those with the highest level of education in low-income countries, 248 (38·0%) of 652 participants were on medication for their diabetes, but only 232 (23·1%) of 1006 participants with low levels of education also took such medication (odds ratio [OR] 0·43, 95% CI 0·34-0·54; p interaction <0·0001; table 3).
We also examined differences in use of secondary prevention medications as a potential explanation of the 
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Participants who had missing information on history of cardiovascular disease at baseline were excluded from this analysis (235 individuals). All ORs are adjusted for age, sex, and centre as a random effect, and treatment for hypertension and treatment for diabetes were additionally adjusted for baseline history of cardiovascular disease. OR=odds ratio. *Interaction between education and country income. †Self-reported or on medications, or blood pressure ≥140/≥90 mm Hg. ‡Self-reported diabetes or on glucose-lowering agent. §At least one of antiplatelet, β blockers, angiotensin-converting-enzyme inhibitors or angiotensin II receptor blockers, or statins. ¶Alternative Healthy Eating Index score in the third tertile. ||Metabolic equivalent score >3000. Table 3 : Proportions of patients with hypertension treatment, diabetes treatment, and secondary prevention treatment by education adjusted for age and sex high mortality among people with low levels of education in low-income and middle-income countries. 11 825 (7·7%) of 153 934 study participants had a previous cardiovascular disease event at baseline (table 3) . Use of at least one medication was reported by 1040 (77·3%) of 1345 participants in high-income countries, 3617 (40·4%) of 8950 participants in middle-income countries, and 240 (15·7%) of 1530 participants in low-income countries.
In high-income countries, people with low education had higher use of any secondary prevention medication (OR 1·82, 95% CI 1·14-2·89), whereas there was no systematic variation in middle-income countries (OR for lowest level vs highest level of education 1·10, 95% CI 0·95-1·28). In low-income countries, 60 (32·1%) of 187 participants with the highest level of education and 67 (8·8%) of 760 participants with no or primary education only used any secondary preventive drug (OR 0·26, 95% CI 0·17-0·42; p interaction <0·0001). Overall, quitting smoking was more common in those with higher education in all types of country-295 (77·4%) of 381 participants in high-income countries, 316 (53·6%) of 590 participants in middle-income countries, and 21 (46·7%) of 45 participants in low-income countries with trade school, college, or university level education, compared with 82 (65·6%) of 125 participants in highincome countries, 676 (48·0%) of 1408 participants in middle-income countries, and 57 (22·6%) of 252 participants in low-income countries with no or primary only education (p interaction 0·0387; table 3). A higher healthy diet score (alternative healthy eating index; appendix) was less common with lower levels of education across high-income, middle-income, and lowincome countries (table 3) . High levels of physical activity were more common among those with low education in low-income countries, but we found no significant interaction between country income and education (p=0·2941; table 3).
Discussion
We found that socioeconomic gradients with respect to cardiovascular disease and mortality varied between high-income, middle-income, and low-income countries, with inverse gradients that were steepest in poorer countries. Variations in traditional risk factors, as captured by the INTERHEART risk score, did not explain the differences in outcomes by socioeconomic status, because risk factors were generally lower in those with lower levels of education in low-income countries. Education, rather than wealth, was the socioeconomic indicator most consistently associated with outcomes, and people with low levels of education in low-income and middle-income countries had a markedly higher risk of major cardio vascular events compared with those with higher levels of education. Socioeconomic differences in primary and secondary prevention were also pronounced, with the least advantaged people (ie, those with low levels of education in low-income countries) receiving very poor secondary prevention, and markedly poorer diabetes and hypertension treatment compared with all other groups. We also observed large differences in CFRs after an acute cardiovascular event across both income level of countries and education level, as well as the household wealth of people within each country; however, details of care during or immediately after an acute event were not available.
The inverse gradient between low socioeconomic status and cardiovascular disease in high-income countries has been well documented. [1] [2] [3] 23, 24 However, although cardiovascular disease mortality has decreased rapidly in high-income countries, low-income and middle-income countries now face the greatest burden of cardiovascular disease. 25 Discussion of the changing patterns in cardiovascular disease has been informed by the concept of the epidemiological transition-the shift from malnutrition and infectious diseases to degenerative or non-communicable diseases, such as cardiovascular disease, as major causes of death and disability, resulting in an increasing average life expectancy and brought about by industrialisation and urbanisation 26, 27 -but what is currently happening is unclear. 7 Although there are data on differences in risk factors by socioeconomic status in low-income and middle-income countries, there are sparse data on whether the incidence and mortality after a cardiovascular disease event vary by socioeconomic status in these countries.
In this study, education was the marker of socioeconomic status that we found to be most clearly linked with cardiovascular outcomes, consistent with our previous report from the INTERHEART study. 28 Low education is a proxy for broader social disadvantage but might directly impair an individual's ability to obtain effective care in several ways, including low awareness of the importance of seeking timely care or reduced access to information on how and where to obtain care and to overcome barriers that exist, both through formal channels and social networks. Lower education also reduces life opportunities more generally, meaning that individuals might not be able to afford necessary health care or might live in neighbourhoods with worse access to health-care facilities, especially in countries without universal health coverage. [29] [30] [31] These factors act throughout a person's life. The effects of social and behavioural factors are important, particularly where health-care systems are unable to compensate for social and economic disadvantages among the poor and less educated. These factors are in line with our finding that, in low-income countries, individuals with lower levels of education with hypertension have a cumulative disadvantage from detection to treatment and control, as previously reported in Colombia. 32 Consistent with this finding, we also showed that those with the lowest levels of education in low-income countries were disadvantaged in access to primary and secondary prevention, and, as previously noted, overall use of these medicines is also alarmingly low in low-income and middle-income countries. 33 Given these findings, it is unsurprising that we observed large differences by education in CFRs in low-income countries. This finding is also consistent with evidence from studies in India, where use of key treatments (thrombolytics, β blockers, lipid-lowering drugs, angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, percutaneous coronary intervention, and coronary artery bypass graft surgery) in patients with acute myocardial infarction differed substantially by socioeconomic status. 34 Although the mechanisms that cause inequalities in access to health care might lead to differences in CFRs, the association with differences in incidence of cardiovascular disease might be less intuitive. However, we do know that most of a sizeable proportion of those enrolled in PURE who had either hypertension, diabetes, or cardiovascular disease were either suboptimally treated or not treated at all, particularly in low-income countries. Thus, there is potential for preventing many events by improving the use of simple proven treatments, especially in individuals with a lower level of education.
In addition to differences in medical management, other factors should be considered, because many people will be healthy before an event and not in need of medication. For example, differences in wealth might affect an individual's ability to afford a healthier diet if certain components of a healthy diet, such as fruits and vegetables, are relatively more expensive and thus unaffordable to many, particularly in poorer countries. 35 People with low levels of education in low-income and middle-income countries had lower risk factor levels but a higher risk of cardiovascular disease compared to those with higher levels of education. This apparent paradox could be due to epigenetics, 36 or weight gain during critical periods in childhood, 37, 38 adolescence, and adulthood, 39 all areas for which systematic information, especially from middle-income and low-income countries, is lacking. Other unmeasured factors might include working conditions, 40 other psychosocial stress factors, 41 and poverty in early life. 42 The main strengths of our study are the inclusion of many communities from several countries at different economic levels, a standardised and systematic approach to data collection, and use of both wealth and education as markers of socioeconomic status. Limitations of our study include grouping together of countries (within the broad categories of low-income or high-income) that are culturally and socially diverse, potentially also with respect to quality of education-the quality of education in low-income countries might be very different to that in high-income countries. However, PURE, like most other surveys on similar topics, did not collect data on the quality of education. Thus, although partici pants in PURE are broadly similar to the populations of the countries concerned, 18 the effect of education and wealth on health might vary between different countries within the same region. This could reflect the mediating effect of welfare policies, or differences between ethnic groups, where belief systems or social networks might confer differing levels of resilience. For example, research in Europe shows that the adverse health effects of unemployment differ among different models of the welfare state, 43 and the association between wealth and self-rated health differs in ethnic groups in the USA. 44 Furthermore, the magnitude of ethnic differences in mortality in some countries, including the USA, varies with independent measures of racism 45 and with measures of political culture. 46 However, disentangling these relationships is extremely complicated in a multi national study because of the very different national contexts.
Another limitation of this study is that the documentation of cardiovascular events, which to a large extent depended on admissions to hospital, might have been less complete for people with scarce financial resources. Therefore, event rates might have been even higher in those with the lowest levels of education or lowest wealth. However, it is possible that CFRs in lowincome and middle-income countries could have been inflated if non-fatal events were incompletely reported. Although we collected information from 20 countries, the results might not necessarily be applicable to other countries in the same income category that were not included. Our study is not intended to be globally representative, but instead the diversity of countries in the study reflects the patterns of different associations between socioeconomic status and risk factors, treatments, and events. To our knowledge, PURE is the largest prospective study to date with in-depth data on socioeconomic status, risk factors, treat ments, and fatal and non-fatal events. Nevertheless, our findings might not be applicable to some countries within a specific economic category-for example, the USA-where the social and health-care systems differ substantially from other high-income countries. Our findings should stimulate similar studies to PURE that involve additional countries. However, our data show considerable consistency in cardiovascular disease and mortality by education group within each of the 20 countries, which indicates our results are likely to be widely applicable.
In conclusion, cardiovascular disease in low-income countries is a problem predominantly among people with lower levels of education, whereas the situation in middle-income countries is more variable. Despite a lower risk factor burden among people with lower levels of education in low-income countries, we found higher rates of major cardiovascular disease. We observed marked differences between those with the highest levels of education and those with the lowest levels of education in the treatment of hyper tension and diabetes, secondary prevention, and CFRs, as markers of substandard management. Given the increasing prevalence of cardiovascular disease, diabetes, and hypertension in lowincome and middle-income countries, these findings are important. The findings of this study emphasise the importance of better education, which in turn can lead to better care and more use of proven pharmacological therapies. Therefore, measures to address the reasons underlying why so many people struggle to obtain education, and to assist them to remedy this situation, are likely to mitigate some of the substantial excess burden of cardiovascular disease and mortality, especially among the least privileged in low-income countries.
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